📣 VC round data is live. Check it out!

Shiseido Valuation Multiples

Discover Shiseido's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Colgate-Palmolive (India), Bausch + Lomb, Dabur India, Yakult Honsha and more.

Shiseido Overview

About Shiseido

Shiseido is a leading Japanese cosmetics manufacturer focused in the prestige and premium categories. Founded in 1872, it was the first Western-style pharmacy in Ginza, Tokyo, and is one of the oldest cosmetics companies globally. Shiseido’s suite of 31 brands, which include its namesake brand, Clé de Peau Beauté, and NARS, had a 10.2% share of Japan’s beauty and personal care market in 2024 according to Euromonitor. It is also ranked in the top 4-5 globally, with around 7% to 8% market share in premium and prestige color cosmetics and skincare. In terms of revenue, Japan and China, which include travel retail, are the two key markets making up 65% of group revenue in 2025.


Founded

1927

HQ

Japan

Employees

33.0K

Financials (LTM)

Revenue: $6B
EBITDA: $728M

EV

$8B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Shiseido Financials

Shiseido reported last 12-month revenue of $6B and EBITDA of $728M.

In the same LTM period, Shiseido generated $5B in gross profit, $728M in EBITDA, and had net loss of ($43M).

Revenue (LTM)


Shiseido P&L

In the most recent fiscal year, Shiseido reported revenue of $6B and EBITDA of $678M.

Shiseido is unprofitable as of last fiscal year, with gross margin of 74%, EBITDA margin of 11%, and net margin of (4%).

See analyst estimates for Shiseido
LTMLast FY202320242025202620272028
Revenue$6B$6B$6B$6B$6B
Gross Profit$5B$5B$4B$5B$5B
Gross Margin77%74%73%76%77%
EBITDA$728M$678M$715M$506M$315M
EBITDA Margin12%11%12%8%5%
EBIT Margin5%5%3%1%(3%)
Net Profit($43M)($255M)$136M($68M)($255M)
Net Margin(1%)(4%)2%(1%)(4%)
Net Debt-$750M---

Financial data powered by Morningstar, Inc.

Shiseido Stock Performance

Shiseido has current market cap of $7B, and enterprise value of $8B.

Market Cap Evolution


Shiseido's stock price is $16.32.

Shiseido share price decreased by 7.5% in the last 30 days, and increased by 0.8% in the last year.

Shiseido has an EPS (earnings per share) of $-0.64.

See more trading valuation data for Shiseido
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8B$7B-0.5%-7.5%-18.7%0.8%$-0.64

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Shiseido Valuation Multiples

Shiseido trades at 1.2x EV/Revenue multiple, and 10.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Shiseido

EV / Revenue (LTM)


Shiseido Financial Valuation Multiples

As of June 3, 2026, Shiseido has market cap of $7B and EV of $8B.

Shiseido has a P/E ratio of (152.2x).

LTMLast FY202320242025202620272028
EV/Revenue1.2x1.2x1.3x1.3x1.3x
EV/EBITDA10.7x11.5x10.9x15.4x24.7x
EV/EBIT23.0x26.9x44.2x164.3x(43.2x)
EV/Gross Profit1.6x1.7x1.7x1.7x1.7x
P/E(152.2x)(25.6x)47.9x(96.3x)(25.6x)
EV/FCF24.7x19.0x37.3xn/m19.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Shiseido Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Shiseido Margins & Growth Rates

Shiseido decreased revenue by 1% but EBITDA grew by 17% in the last fiscal year.

In the most recent fiscal year, Shiseido reported gross margin of 74%, EBITDA margin of 11%, and net margin of (4%).

See estimated margins and future growth rates for Shiseido

Shiseido Margins

Last FY202420252026202720282029
Gross Margin74%76%77%77%
EBITDA Margin11%8%5%13%
EBIT Margin5%1%(3%)6%
Net Margin(4%)(1%)(4%)4%
FCF Margin6%(0%)7%7%

Shiseido Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(1%)2%(2%)3%
Gross Profit Growth3%6%(1%)3%
EBITDA Growth17%(29%)(38%)153%
EBIT Growth40%(73%)(480%)(325%)
Net Profit Growth(203%)(150%)276%(203%)
FCF Growth11%(107%)(2940%)11%

Data powered by FactSet, Inc. and Morningstar, Inc.

Shiseido Operational KPIs

Shiseido's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Shiseido's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Shiseido's Rule of X is 21% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Shiseido
LTMLast FY202320242025202620272028
Rule of 4012%16%---
Bessemer Rule of X14%21%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue29%29%--30%
G&A Expenses to Revenue-72%72%76%75%
R&D Expenses to Revenue4%4%--4%
Opex to Revenue-77%70%75%80%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Shiseido Competitors

Shiseido competitors include Colgate-Palmolive (India), Bausch + Lomb, Dabur India, Yakult Honsha, AmorePacific, Fielmann Group, Giant Biogene, GSK India, Proya Cosmetics and Lenskart.

Most Shiseido public comparables operate across Health & Beauty.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Colgate-Palmolive (India)8.8x8.7x27.4x28.0x
Bausch + Lomb2.0x1.9x11.4x10.7x
Dabur India5.4x5.3x23.6x28.2x
Yakult Honsha1.3x1.3x6.0x8.8x
AmorePacific1.4x1.3x9.5x9.2x
Fielmann Group1.8x1.7x7.5x7.4x
Giant Biogene3.3x3.2x7.5x8.0x
GSK India9.0x8.8x23.2x25.6x

This data is available for Pro users. Sign up to see all Shiseido competitors and their valuation data.

Start Free Trial

Acquisitions by Shiseido

Shiseido has acquired 4 companies to date.

Last acquisition by Shiseido was on September 29th 2022. Shiseido acquired Gallinée for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Shiseido

Gallinée
Drunk Elephant
MATCHCo
Gurwitch Products
Description
Galliée is a London-headquartered skincare brand that formulates products nurturing the skin microbiome with prebiotics, probiotics, and lactic acid complexes. Developed by pharmacist Marie Absolam, the range includes face washes, serums, and moisturizers sold in Europe and the US through Sephora and Cult Beauty. The patented formula draws from microbiome research presented at dermatology congresses.
Drunk Elephant is a Houston-based skincare brand offering products free of essential oils, silicones, fragrances, and drying alcohols. The line includes cleansers like Beste No. 9 Jelly Cleanser, serums such as C-Firma Vitamin C serum, and moisturizers like Lala Retro Whipped Cream. Acquired by Shiseido in 2019, Drunk Elephant maintains a clinical formulation approach for all skin types.
MATCHCo is a California-based beauty technology company specializing in personalized foundation products. Founded in 2013, it uses a mobile app available on Apple's App Store to scan users' skin tones and blend custom-matched foundations at scale. The app, launched in November 2015, earned accolades as Best New App and Best of November, along with Beauty Breakthrough Awards from Teen Vogue and Good Housekeeping. MATCHCo's patented technology processes skin data to produce over 4 million shade variations, serving consumers through direct-to-consumer shipping from its San Francisco facility.
Gurwitch Products is a marketer of prestige cosmetics and skincare brands including Laura Mercier and Journey Collection. Based in the United States, the company distributes through department stores and specialty retailers. In the fiscal year ending 2015, it reported net sales of $175 million, focusing on makeup foundations, lip products, and facial treatments.
HQ CountryUnited KingdomUnited StatesUnited StatesUnited States
HQ City
London
Houston, TX
Los Angeles, CA
Houston, TX
Deal Date29 Sep 20228 Oct 201918 Jan 20172 Jun 2016
Valuationundisclosed$845Mundisclosed$260M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Shiseido acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Shiseido

Shiseido has invested in 4 companies to date.

Latest investment by Shiseido was on March 10th 2025. Shiseido invested in Chitose Group in their $28M Undisclosed stage round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Shiseido

Chitose Group
Chitose Group
Chuangjian Medical
Airfree SAS
Description
Chitose Group is a biotechnology conglomerate with operations in Singapore, Japan, and Indonesia focused on microalgae cultivation for sustainable products. It engineers strains for DHA omega-3 oils used in infant formula by Nestle and DSM, biofuel feedstocks, and animal feed additives replacing fishmeal. The group operates 50-hectare photobioreactor farms producing 10,000 tons annually, advancing carbon capture in aquaculture and cosmetics.
Chitose Group is a biotechnology conglomerate with operations in Singapore, Japan, and Indonesia focused on microalgae cultivation for sustainable products. It engineers strains for DHA omega-3 oils used in infant formula by Nestle and DSM, biofuel feedstocks, and animal feed additives replacing fishmeal. The group operates 50-hectare photobioreactor farms producing 10,000 tons annually, advancing carbon capture in aquaculture and cosmetics.
Chuangjian Medical pursues technological innovation through creation, sales, and research and development of novel protein-based and nucleic acid-based medicines. The company advances biotech therapeutics from trautec.com.cn.
Airfree SAS is a French duty-free retailer operating shops at airports including Paris Charles de Gaulle and Nice CĂ´te d'Azur. It sells luxury goods, cosmetics, and regional wines through physical stores and digital platforms. Paris-headquartered Airfree SAS manages e-commerce for airside passengers. Established in 2015, it focuses on personalized shopping via app-based pre-orders.
HQ CountryJapanJapanChinaFrance
HQ City
Kawasaki
Kawasaki
Changzhou
Paris
Deal Date10 Mar 202513 Jul 202310 Aug 202227 May 2019
RoundUndisclosed stageUndisclosed stageSeries ASeries A
Raised$28M$22M$29M$3M
InvestorsAmano Enzyme; Ikeda Saccharification Industry; JAFCO Asia; Mers Line; Mitsubishi Kakoki Kaisha; Mitsui Kinzoku Co; Mizuho Financial Group; NGK Insulators; NSK; Shinsho; Shiseido; Sumitomo Mitsui Trust BankAmano Enzyme; Ikeda Saccharification Industry; Mers Line; Mitsubishi Kakoki Kaisha; Mitsui Kinzoku Co; NGK Insulators; Shinsho; ShiseidoBeijing Huafang Investment; CDH Investments; Holley Group; ShiseidoShiseido; Starburst Accelerator
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Shiseido investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Shiseido

When was Shiseido founded?Shiseido was founded in 1927.
Where is Shiseido headquartered?Shiseido is headquartered in Japan.
How many employees does Shiseido have?As of today, Shiseido has over 33K employees.
Who is the CEO of Shiseido?Shiseido's CEO is Kentaro Fujiwara.
Is Shiseido publicly listed?Yes, Shiseido is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Shiseido?Shiseido trades under 4911 ticker.
When did Shiseido go public?Shiseido went public in 1949.
Who are competitors of Shiseido?Shiseido main competitors include Colgate-Palmolive (India), Bausch + Lomb, Dabur India, Yakult Honsha, AmorePacific, Fielmann Group, Giant Biogene, GSK India, Proya Cosmetics, Lenskart.
What is the current market cap of Shiseido?Shiseido's current market cap is $7B.
What is the current revenue of Shiseido?Shiseido's last 12 months revenue is $6B.
What is the current revenue growth of Shiseido?Shiseido revenue growth (NTM/LTM) is 1%.
What is the current EV/Revenue multiple of Shiseido?Current revenue multiple of Shiseido is 1.2x.
What is the current EBITDA of Shiseido?Shiseido's last 12 months EBITDA is $728M.
What is Shiseido's EBITDA margin?Shiseido's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Shiseido?Current EBITDA multiple of Shiseido is 10.7x.
What is the current FCF of Shiseido?Shiseido's last 12 months FCF is $315M.
What is Shiseido's FCF margin?Shiseido's last 12 months FCF margin is 5%.
What is the current EV/FCF multiple of Shiseido?Current FCF multiple of Shiseido is 24.7x.
How many companies Shiseido has acquired to date?As of June 2026, Shiseido has acquired 4 companies.
What was the largest acquisition by Shiseido?$845M acquisition of Drunk Elephant on 8th October 2019 was the largest M&A Shiseido has done to date.
What companies Shiseido acquired?Shiseido acquired Drunk Elephant, Gurwitch Products, MATCHCo, and Gallinée.
In how many companies Shiseido has invested to date?As of June 2026, Shiseido has invested in 4 companies.
What was the last Shiseido investment?On 10th March 2025 Shiseido invested in Chitose Group, participating in a $28M Undisclosed stage round, alongside Amano Enzyme, Ikeda Saccharification Industry, JAFCO Asia, Mers Line, Mitsubishi Kakoki Kaisha, Mitsui Kinzoku Co, Mizuho Financial Group, NGK Insulators, NSK, Shinsho, and 1 other investor.
In what companies Shiseido invested in?Shiseido invested in FiNC Technologies, Chuangjian Medical, Chitose Group, and Airfree SAS.

See public comps similar to Shiseido

Lists including Shiseido

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial